Trump’s Diagnosis Fuels Uncertainty for Skittish U.S. Stock Market

(Reuters) – Investors are gauging how a potential deterioration in President Donald Trump’s health could impact asset prices in coming weeks, as the U.S. leader remains hospitalized after being diagnosed with COVID-19.

So far, markets have been comparatively sanguine: hopes of a breakthrough in talks among U.S. lawmakers on another stimulus package took the edge off a stock market selloff on Friday, with the S&P 500 losing less than 1% and so-called safe-haven assets seeing limited demand. News of Trump’s hospitalization at a military medical center outside Washington, where he remained on Saturday, came after trading ended on Friday.

Many investors are concerned, however, that a serious decline in Trump’s health less than a month before Americans go to the polls on Nov. 3 could roil a U.S. stock market that recently notched its worst monthly performance since its selloff in March while causing turbulence in other assets. Read more…..


Chart of the Day

Icarus TV

CNBC’s “Squawk on the Street” watch how stocks perform as the market opens, and the team discusses how the White House is responding to President Trump’s coronavirus diagnosis

Share This Post

Leave a Reply